Despite calls to reduce imports from China, India's reliance on its hostile neighbour for the pharmaceutical sector remains. At least 60% of India's Active Pharmaceutical Ingredient (API) requirements come from China. ET's Divya Rajagopal takes a look at how the Indian pharma industry is heavily dependent on China and what can it do to wean off. Watch now.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service